日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis

血清素转运蛋白通过调节肿瘤内血清素轴抑制抗肿瘤免疫。

Bo Li ,James Elsten-Brown ,Miao Li ,Enbo Zhu ,Zhe Li ,Yuning Chen ,Elliot Kang ,Feiyang Ma ,Jennifer Chiang ,Yan-Ruide Li ,Yichen Zhu ,Jie Huang ,Audrey Fung ,Quentin Scarborough ,Robin Cadd ,Jin J Zhou ,Arnold I Chin ,Matteo Pellegrini ,Lili Yang

Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method

利用临床指导的培养方法,从造血干细胞和祖细胞生成同种异体CAR-NKT细胞

Yan-Ruide Li # ,Yang Zhou # ,Jiaji Yu # ,Yu Jeong Kim ,Miao Li ,Derek Lee ,Kuangyi Zhou ,Yuning Chen ,Yichen Zhu ,Yu-Chen Wang ,Zhe Li ,Yanqi Yu ,Zachary Spencer Dunn ,Wenbin Guo ,Xinjian Cen ,Tiffany Husman ,Aarushi Bajpai ,Adam Kramer ,Matthew Wilson ,Ying Fang ,Jie Huang ,Shuo Li ,Yonggang Zhou ,Yuchong Zhang ,Zoe Hahn ,Enbo Zhu ,Feiyang Ma ,Calvin Pan ,Aldons J Lusis ,Jin J Zhou ,Christopher S Seet ,Donald B Kohn ,Pin Wang ,Xianghong Jasmine Zhou ,Matteo Pellegrini ,Benjamin R Puliafito ,Sarah M Larson ,Lili Yang

Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity

利用脐带血CD34⁺ HSPC来源的间皮素特异性CAR-NKT细胞靶向治疗三阴性乳腺癌,具有强大的抗肿瘤活性

Yan-Ruide Li ,Xinyuan Shen ,Yichen Zhu ,Zhe Li ,Ryan Hon ,Yanxin Tian ,Jie Huang ,Annabel S Zhao ,Nathan Y Ma ,Catherine Zhang ,David Lin ,Karine Sargsyan ,Yuan Yuan ,Lili Yang

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies

用于治疗骨髓驻留髓系恶性肿瘤的同种异体CD33靶向CAR-NKT细胞

Yan-Ruide Li # ,Ying Fang # ,Siyue Niu # ,Yichen Zhu # ,Yuning Chen ,Zibai Lyu ,Enbo Zhu ,Yanxin Tian ,Jie Huang ,Valerie Rezek ,Scott Kitchen ,Tzung Hsiai ,Jin J Zhou ,Pin Wang ,Wanxing Chai-Ho ,Sunmin Park ,Christopher S Seet ,Caspian Oliai ,Lili Yang

Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety

异体干细胞工程化EGFRvIII特异性CAR-NKT细胞治疗胶质母细胞瘤,具有更高的疗效和安全性

Yan-Ruide Li ,Yichen Zhu ,Zhe Li ,Xinyuan Shen ,Tyler Halladay ,Christopher Tse ,Yanxin Tian ,Jie Huang ,Annabel S Zhao ,Nathan Y Ma ,Catherine Zhang ,David A Nathanson ,Robert M Prins ,Lili Yang

Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells

利用CD70靶向异基因CAR-NKT细胞对转移性肾细胞癌进行多模式靶向治疗

Yan-Ruide Li,Junhui Hu,Zhe Li,Enbo Zhu,Yuning Chen,Tyler Halladay,Xinyuan Shen,Ying Fang,Yichen Zhu,Zibai Lyu,Yanxin Tian,Jie Huang,Annabel S Zhao,Nathan Y Ma,Catherine Zhang,Yongpeng Xie,Hanwei Zhang,Tzung Hsiai,Arnold I Chin,Lily Wu,Lili Yang

SynthSoM: A synthetic intelligent multi-modal sensing-communication dataset for Synesthesia of Machines (SoM)

SynthSoM:用于机器联觉(SoM)的合成智能多模态感知通信数据集

Cheng, Xiang; Huang, Ziwei; Yu, Yong; Bai, Lu; Sun, Mingran; Han, Zengrui; Zhang, Ruide; Li, Sijiang

Protocol for assessing pharmacokinetics and pharmacodynamics of human CAR-NKT cells in humanized mouse models using bioluminescence imaging

利用生物发光成像技术评估人源化小鼠模型中人源CAR-NKT细胞药代动力学和药效学的方案

Zibai Lyu ,Yan-Ruide Li ,Lili Yang

Protocol to profile tumor and microenvironment from ovarian cancer patient samples and evaluate cell-based therapy using in vitro killing assays

利用体外杀伤试验分析卵巢癌患者样本中的肿瘤和微环境,并评估基于细胞的疗法的方案

Yan-Ruide Li,Christopher J Ochoa,Zibai Lyu,Yichen Zhu,Yuning Chen,Gabriella DiBernardo,Lauryn Ruegg,Sanaz Memarzadeh,Lili Yang

Protocol to generate allorejection-resistant universal CAR-NKT cells and evaluate their efficacy, mechanism of action, safety, and immunogenicity

生成抗同种异体排斥的通用CAR-NKT细胞并评估其疗效、作用机制、安全性和免疫原性的方案

Ying Fang ,Yuning Chen ,Yichen Zhu ,Yanxin Tian ,Yan-Ruide Li ,Lili Yang